These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3817309)

  • 1. Bio-availability and dissolution of three phenytoin preparations for children.
    Hodges S; Forsythe WI; Gillies D; Remington H; Cawood A
    Dev Med Child Neurol; 1986 Dec; 28(6):708-12. PubMed ID: 3817309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
    Brandau R; Wehnert HU
    Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption and metabolism of phenytoin from tablets and capsules.
    Smith TC; Kinkel A
    Clin Pharmacol Ther; 1976 Dec; 20(6):738-42. PubMed ID: 791565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of phenytoin sodium capsules available in Thailand. Part I: In vitro study.
    Suthisisang C; Payakachat N
    J Med Assoc Thai; 1998 Jan; 81(1):58-63. PubMed ID: 9470323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the bioavailability of two brands of phenytoin.
    Gibberd FB; Spencer KM; Webley M; Berry D
    Br J Clin Pharmacol; 1982 Mar; 13(3):455-6. PubMed ID: 7059449
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenytoin I: in vitro-in vivo correlation for 100-mg phenytoin sodium capsules.
    Shah VP; Prasad VK; Alston T; Cabana BE; Gural RP; Meyer MC
    J Pharm Sci; 1983 Mar; 72(3):306-8. PubMed ID: 6687736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single daily dose of diphenylhydantoin in children.
    Buchanan RA; Turner JL; Moyer CE; Heffelfinger JC
    J Pediatr; 1973 Sep; 83(3):479-83. PubMed ID: 4725154
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2001; (4):CD001769. PubMed ID: 11687121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for 25 mg tablets of phenytoin.
    Kshirsagar NA; Joshi MV; Shah PU; Dalvi SS
    J Assoc Physicians India; 1991 May; 39(5):395-6. PubMed ID: 1960157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bio-availability of phenytoin free-acid serum level determinations whilst using a lactose-based tablet-preparation (author's transl)].
    Fritsch G; Haidvogl M; Füger G; Urban C
    Monatsschr Kinderheilkd; 1980 Oct; 128(10):648-50. PubMed ID: 6107823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral phenytoin in infancy: dose requirement, absorption, and elimination.
    Albani M; Wernicke I
    Pediatr Pharmacol (New York); 1983; 3(3-4):229-36. PubMed ID: 6677874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of relative humidity on drug release from phenytoin sodium tablets and capsules. Part 1: Commercial preparations.
    Akbuğa J; Ari-Ulubelen A; Bayraktar-Alpmen G
    Pharmazie; 1984 Aug; 39(8):560-1. PubMed ID: 6504981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin II: in vitro-in vivo bioequivalence standard for 100-mg phenytoin sodium capsules.
    Shah VP; Prasad VK; Freeman C; Skelly JP; Cabana BE
    J Pharm Sci; 1983 Mar; 72(3):309-10. PubMed ID: 6842384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of bioavailabilities of different phenytoin preparations.
    Fukuyama Y; Kitahara H; Goto T
    Brain Dev; 1982; 4(1):35-43. PubMed ID: 7065375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.
    Bielmann P; Levac T
    Eur J Clin Pharmacol; 1978 Nov; 14(3):191-4. PubMed ID: 729613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of two different phenytoin preparations. Evidence for an age dependency.
    Matsukura M; Ikeda T; Higashi A; Matsuda I
    Dev Pharmacol Ther; 1984; 7(3):160-8. PubMed ID: 6723491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.